Radium-223 (Rad) and niraparib (Nira) treatment (tx) in castrate-resistant prostate cancer (CRPC) patients (pts) with and without prior chemotherapy (chemo).

被引：0
|
作者：
Kelly, William Kevin
Leiby, Benjamin
Einstein, David Johnson
Szmulewitz, Russell Zelig
Sartor, A. Oliver
Yang, Eddy Shih-Hsin
Sonpavde, Guru
机构：
[1] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, Philadelphia, PA USA
[3] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[4] Univ Chicago, Chicago, IL 60637 USA
[5] Tulane Canc Ctr, New Orleans, LA USA
[6] Univ Alabama Birmingham, Birmingham, AL USA
[7] Dana Farber Canc Inst, Dept Genitourinary Oncol, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5540
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Biomarker analysis of phase (Ph) IB trial of radium-223 (Rad) and niraparib (Nira) in patients (Pts) with metastatic castrate-resistant prostate cancer (mCRPC) (NiraRad).
    Yang, Eddy Shih-Hsin
    Leiby, Benjamin
    Sonpavde, Guru P.
    Einstein, David Johnson
    Quinn, Zachary L.
    Szmulewitz, Russell Zelig
    Sartor, A. Oliver
    Kelly, William Kevin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] Radium-223 for Metastatic Castrate-Resistant Prostate Cancer
    Sindhu, Kunal K.
    Nehlsen, Anthony D.
    Stock, Richard G.
    [J]. PRACTICAL RADIATION ONCOLOGY, 2022, 12 (04) : 312 - 316
  • [3] Phase I Study of Niraparib in Combination with Radium-223 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer
    Quinn, Zachary
    Leiby, Benjamin
    Sonpavde, Guru
    Choudhury, Atish D.
    Sweeney, Christopher
    Einstein, David
    Szmulewitz, Russell
    Sartor, Oliver
    Knudsen, Karen
    Yang, Eddy Shih-Hsin
    Kelly, Wm. Kevin
    [J]. CLINICAL CANCER RESEARCH, 2023, 29 (01) : 50 - 59
  • [4] Radium-223 therapy for metastatic castrate-resistant prostate cancer
    Lehman, Ashley
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [5] Radium-223 therapy for metastatic castrate-resistant prostate cancer
    Lehman, Ashley
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [6] Radium-223 in Heavily Pretreated Metastatic Castrate-Resistant Prostate Cancer
    Modi, Dipenkumar
    Hwang, Clara
    Mamdani, Hirva
    Kim, Seongho
    Gayar, Hesham
    Vaishampayan, Ulka
    Joyrich, Richard
    Heath, Elisabeth I.
    [J]. CLINICAL GENITOURINARY CANCER, 2016, 14 (05) : 373 - 380
  • [7] Clinical experience with radium-223 in the treatment of patients with advanced castrate-resistant prostate cancer and bone metastases
    Exadaktylou, P.
    Paschali, A.
    Panagiotidis, E.
    Papadopoulos, N.
    Kalathas, T.
    Giannoula, E.
    Kotzasarlidou, M.
    Chatzipavlidou, V.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S569 - S570
  • [8] Pain Response to Radium-223 in Men With Metastatic Castrate-Resistant Prostate Cancer
    Zhang, I.
    Gilbo, P.
    Cox, B. W.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E530 - E530
  • [9] Clinical experience with radium-223 in the treatment of patients with advanced castrate-resistant prostate cancer and symptomatic bone metastases
    Hague, Christina
    Logue, John P.
    [J]. THERAPEUTIC ADVANCES IN UROLOGY, 2016, 8 (03) : 175 - 180
  • [10] Clinical response to radium-223 dichloride in men with metastatic castrate-resistant prostate cancer
    Zhang, Isabella
    Gilbo, Philip
    Kohn, Nina
    Cox, Brett
    [J]. PRACTICAL RADIATION ONCOLOGY, 2018, 8 (06) : 452 - 457
12345